Accepted
at 2:26 a.m. Nov, 01, 2023
by
shmuelsash
Author:
oneMedGuy
Type of change:
Updated content
Rationale for change
Based on FA and Amboss it causes general vasodilation and decreases both preload and afterload
https://next.amboss.com/us/article/em0xeg?utm_source=navbar&utm_medium=anki&utm_campaign=anki&utm_term=milrinone&guid=zwlJScW%255D7o&aid=2602087c-5151-49c9-a3cb-1435332f5ff7&uid=us_2p9p4a#Z431442776227da3581151dd86db0ddfb
Before
After
Text
Text
Text
Text
Extra
- A phosphodiesterase type 3 (PDE-3) inhibitor with positive inotropic and vasodilatory effects
- Used in the treatment of acute HF; should not be used in severely hypotensive patients
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid





Sketchy






Sketchy 2
Empty field
Picmonic
Empty field
Pixorize




Physeo
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
Bootcamp
Watch associated Bootcamp video - Vasodilation and Vasoconstriction : Pharmacologic Targets
Watch associated Bootcamp video - Autonomic System : Phosphodiesterase Inhibitors
Watch associated Bootcamp video - Autonomic System : Phosphodiesterase Inhibitors
OME
Empty field
Additional Resources
One by one
Empty field


